Hyperparathyroidism, Hyperphosphatemia, and Hyperkalemia in Chronic Kidney Disease: Opportunity Assessment and Forecast

• There will be an overall increase in the diagnosed prevalent cases of CKD- HPT, HP and HK in the 7MM across the forecast period.
• Across the 7MM, the mainstay treatment for HPT, HP, and HK involves phosphate binders, calcimimetics, and potassium binders
• Significant clinical and environmental unmet needs remain in the CKD- HPT, HP and HK market.
• The Combined sales for CKD-HPT, HP, and HK are expected to grow modestly over the forecast period, from $2.6 billion in 2024 to $4.0 billion by 2034, at a compound annual growth rate (CAGR) of 4.4%.

Report Scope

• Overview of CKD, including epidemiology, symptoms, diagnosis, and disease management.
• Annualized CKD- HPT, HP and HK therapeutics market revenue in 7MM (US, 5EU, and Japan), annual cost of therapy and treatment usage pattern in 2024 and forecast for 10 years to 2034.
• Key topics covered include strategic competitor assessment, market characterization, unmet needs, clinical trial mapping and implications for the CKD- HPT, HP and HK therapeutics market.
• Pipeline analysis, comprehensive data assessing emerging trends and mechanisms of action under development for CKD- HPT, HP and HK treatment. The most promising candidates in late-stage development are profiled.
• Analysis of the current and future market competition in the 7MM CKD- HPT, HP and HK therapeutics market. Insightful review of the key industry drivers, restraints, and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.

Reasons to Buy

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving the CKD- HPT, HP and HK therapeutics market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the CKD- HPT, HP and HK therapeutics market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
• Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.